Clinical features and epidemiological significance of pertussis in infants
YAO Kai-Hu, HU Ya-Hong, YUAN Lin
Author information+
National Center for Children's Health/Beijing Children's Hospital, Capital Medical University/Laboratory of Microbiology, Beijing Pediatric Research Institute/National Key Discipline of Pediatrics (Capital Medical University)/Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, China (Email: yaokaihu@bch.com.cn)
Infantile pertussis is clear evidence for the persistent transmission of pertussis in communities. Infants are the most vulnerable population for pertussis infection and are also important nodes in pertussis transmission networks in communities, and therefore, the prevention of infantile pertussis is the core of prevention and control measures against pertussis including vaccine immunization. Although the cases of pertussis reported in China are mainly infants with pertussis, the actual number of infants with pertussis might be higher than the reported number. It is necessary in clinical practice to improve the awareness of this disease and promote related laboratory tests. On the basis of emphasizing the identification of pertussis in infants, timely diagnosis and treatment, follow-up visits, and standard management of the close contacts of infants with pertussis should be performed to reduce and block the community transmission of pertussis. Citation:Chinese Journal of Contemporary Pediatrics, 2022, 24(9): 955-959
YAO Kai-Hu, HU Ya-Hong, YUAN Lin.
Clinical features and epidemiological significance of pertussis in infants[J]. Chinese Journal of Contemporary Pediatrics. 2022, 24(9): 955-959 https://doi.org/10.7499/j.issn.1008-8830.2205033
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 蔡路奎, 李婧妍, 姬秋彦, 等. 2004-2019年我国百日咳报告病例流行病学特征分析[J]. 预防医学情报杂志, 2021, 37(8): 1036-1043. 2 Liu D, Du Q, Yuan L, et al. Retrospective analysis of bacterial culture-confirmed pertussis cases in Beijing Children's Hospital from 2014 to 2019 reveals prevention and control of the grim situation in mainland China[J]. Expert Rev Vaccines, 2021, 20(5): 577-583. PMID: 33691571. DOI: 10.1080/14760584.2021.1899822. 3 黄辉, 邓莉, 张榕, 等. 儿童百日咳疑似病例400例临床特征分析[J]. 中华实用儿科临床杂志, 2021, 36(16): 1245-1248. DOI: 10.3760/cma.j.cn101070-20200514-00823. 4 中华预防医学会, 中华预防医学会疫苗与免疫分会. 中国百日咳行动计划专家共识[J]. 中华流行病学杂志, 2021, 42(6): 955-965. PMID: 33874699. DOI: 10.3760/cma.j.cn112338-20210308-00186. 5 张喆, 华春珍, 谢永平, 等. 百日咳患儿211例的临床特点、菌株体外耐药性和治疗效果分析[J]. 中华传染病杂志, 2021, 39(3): 168-174. DOI: 10.3760/cma.j.cn311365-20200302-00182. 6 徐周, 王红梅, 吴小颖, 等. 儿童百日咳临床流行特征及其密切接触者感染现况[J]. 中华医学杂志, 2021, 101(44): 3650-3654. PMID: 34823282. DOI: 10.3760/cma.j.cn112137-20210301-00523. 7 WHO. Pertussis vaccines: WHO position paper, August 2015—recommendations[J]. Vaccine, 2016, 34(12): 1423-1425. PMID: 26562318. DOI: 10.1016/j.vaccine.2015.10.136. 8 孟庆红, 史伟, 姚开虎. 百日咳自然感染和疫苗诱导的免疫反应研究进展[J]. 中华实用儿科临床杂志, 2017, 32(10): 794-796. DOI: 10.3760/cma.j.issn.2095-428X.2017.10.020. 9 Meng QH, Liu Y, Yu JQ, et al. Seroprevalence of maternal and cord antibodies specific for diphtheria, tetanus, pertussis, measles, mumps and rubella in Shunyi, Beijing[J]. Sci Rep, 2018, 8(1): 13021. PMID: 30158679. PMCID: PMC6115429. DOI: 10.1038/s41598-018-31283-y. 10 宁桂军, 高源, 吴丹, 等. 中国2011-2017年百日咳流行病学特征分析[J]. 中国疫苗和免疫, 2018, 24(3): 264-267. 11 姚开虎, 李丽君. 重症百日咳的诊断及其死亡风险因素研究进展[J]. 中华实用儿科临床杂志, 2019, 34(22): 1681-1685. DOI: 10.3760/cma.j.issn.2095-428X.2019.22.001. 12 Gabutti G, Cetin I, Conversano M, et al. Experts' opinion for improving pertussis vaccination rates in adolescents and adults: a call to action[J]. Int J Environ Res Public Health, 2022, 19(7): 4412. PMID: 35410091. PMCID: PMC8998413. DOI: 10.3390/ijerph19074412. 13 吴少珍, 陶方超, 邓坤仪, 等. 190例儿童百日咳的临床特征和实验室指标分析[J]. 大医生, 2021, 6(14): 107-110. 14 唐琦钦, 甘川, 吴小英, 等. 百日咳疫苗接种对婴幼儿百日咳临床表现的影响[J]. 中国当代儿科杂志, 2021, 23(2): 138-142. DOI: 10.7499/j.issn.1008-8830.2008081. 15 朱慧慧, 吕芳芳, 徐铭, 等. 儿童百日咳的临床特征研究及诊断标准探讨[J]. 四川大学学报(医学版), 2021, 52(5): 839-843. PMID: 34622602. DOI: 10.12182/20210960104. 16 吴小英, 李丽君, 姚开虎, 等. 儿童重症百日咳治疗策略研究进展[J]. 中国当代儿科杂志, 2021, 23(2): 192-197. PMID: 33627217. PMCID: PMC7921532. DOI: 10.7499/j.issn.1008-8830.2010105. 17 Chow MY, Khandaker G, McIntyre P. Global childhood deaths from pertussis: a historical review[J]. Clin Infect Dis, 2016, 63(suppl 4): S134-S141. PMID: 27838665. PMCID: PMC5106618. DOI: 10.1093/cid/ciw529. 18 吴小英, 甘川. 婴幼儿重症百日咳死亡相关因素分析[J]. 临床儿科杂志, 2020, 38(6): 432-437. DOI: 10.3969/j.issn.1000-3606.2020.06.008. 19 Shi T, Wang L, Du S, et al. Mortality risk factors among hospitalized children with severe pertussis[J]. BMC Infect Dis, 2021, 21(1): 1057. PMID: 34641796. PMCID: PMC8506076. DOI: 10.1186/s12879-021-06732-1. 20 Wang C, Zhang H, Zhang Y, et al. Analysis of clinical characteristics of severe pertussis in infants and children: a retrospective study[J]. BMC Pediatr, 2021, 21(1): 65. PMID: 33546645. PMCID: PMC7863367. DOI: 10.1186/s12887-021-02507-4. 21 Tao Y, Tang M, Luo L, et al. Identification of etiologic agents and clinical characteristics for patients suspected of having pertussis in a large children's hospital in China[J]. Ann Transl Med, 2019, 7(18): 443. PMID: 31700879. PMCID: PMC6803182. DOI: 10.21037/atm.2019.08.85. 22 刘娟, 卢秀兰, 朱德胜, 等. 换血疗法在儿童重症百日咳肺炎中的临床应用[J]. 中国小儿急救医学, 2021, 28(7): 625-629. DOI: 10.3760/cma.j.issn.1673-4912.2021.07.017. 23 姚开虎, 史伟, 袁林, 等. 百日咳典型表现中英文描述的比较和(类)百日咳综合征诊断的建议[J]. 中国当代儿科杂志, 2020, 22(7): 679-683. PMID: 32669160. PMCID: PMC7389631. DOI: 10.7499/j.issn.1008-8830.2004021. 24 Tessier E, Campbell H, Ribeiro S, et al. Impact of the COVID-19 pandemic on Bordetella pertussis infections in England[J]. BMC Public Health, 2022, 22(1): 405. PMID: 35220973. PMCID: PMC8882439. DOI: 10.1186/s12889-022-12830-9. 25 许秀妆, 章金灿. 裂隙淋巴细胞辅助诊断儿童百日咳的临床价值[J]. 中国当代儿科杂志, 2020, 22(9): 996-1000. PMID: 32933633. PMCID: PMC7499451. DOI: 10.7499/j.issn.1008-8830.2002205. 26 伍金倩, 黄道连, 崔经和, 等. 外周血裂隙淋巴细胞计数对百日咳诊断价值的研究[J]. 实验与检验医学, 2020, 38(5): 872-875. DOI: 10.3969/j.issn.1674-1129.2020.05.017. 27 World Health Organization. Pertussis: vaccine preventable diseases surveillance standards[EB/OL]. (2018-09-04)[2022-04-20]. https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-pertussis. 28 中华医学会儿科学分会感染学组, 《中华儿科杂志》编辑委员会. 中国儿童百日咳诊断及治疗建议[J]. 中华儿科杂志, 2017, 55(8): 568-572. PMID: 28822429. DOI: 10.3760/cma.j.issn.0578-1310.2017.08.004. 29 Cimolai N. Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences[J]. Int J Antimicrob Agents, 2021, 57(3): 106257. PMID: 33310117. DOI: 10.1016/j.ijantimicag.2020.106257. 30 中华医学会儿科学分会临床药理学组, 《中华儿科杂志》编辑委员会. 中国儿科超说明书用药专家共识[J]. 中华儿科杂志, 2016, 54(2): 101-103. PMID: 26875459. DOI: 10.3760/cma.j.issn.0578-1310.2016.02.007. 31 李丽君, 刘莹, 贾举, 等. 新生儿百日咳致病株抗菌药物敏感性和抗原基因型研究[J]. 中国当代儿科杂志, 2019, 21(3): 208-213. PMID: 30907341. PMCID: PMC7389359. DOI: 10.7499/j.issn.1008-8830.2019.03.004. 32 Mi YM, Hua CZ, Fang C, et al. Effect of macrolides and β-lactams on clearance of Bordetella pertussis in the nasopharynx in children with whooping cough[J]. Pediatr Infect Dis J, 2021, 40(2): 87-90. PMID: 33021592. DOI: 10.1097/INF.0000000000002911.